NCT06592287 2024-09-19The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric CancerHuazhong University of Science and TechnologyPhase 1/2 Not yet recruiting66 enrolled